Table 2.
Variable | Total (74) | No lesion (23) | Minor lesion (22) | Intermediate lesion (20) | Major lesion (9) | p-value |
---|---|---|---|---|---|---|
Glucose, mmol/L | 6.17±2.95 | 5.76±2.34 | 5.68±1.82 | 7.10±4.37 | 6.38±2.62 | 0.408 |
Total cholesterol, mmol/L | 4.73±1.20 | 4.47±1.04 | 4.58±1.02 | 5+11±1.44 | 4.91±1.42 | 0.305 |
HDL cholesterol, mmol/L | 0.98±0.27 | 1.04±0.31 | 0.93±0.22 | 0.93±0.26 | 1.03±0.29 | 0.414 |
LDL cholesterol, mmol/L | 2.86±1.07 | 2.64±0.90 | 2.68±0.89 | 3.16±1.31 | 3.22±1.28 | 0.261 |
Triglycerides, mmol/L | 1.97±1.48 | 1.70±1.30 | 2.11±1.44 | 2.37±1.87 | 1.46±0.76 | 0.157 |
ALT, µKat/L | 0.51±0.36 | 0.50±0.39 | 0.52±0.23 | 0.48±0.45 | 0.58±0.39 | 0.298 |
AST, µKat/L | 0.57±0.32 | 0.65±0.38 | 0.54±0.29 | 0.51±0.22 | 0.63±0.39 | 0.639 |
Urea, mmol/L | 13.45±3.72 | 13.03±3.68 | 13.52±3.26 | 14.10±4.40 | 12.98±3.82 | 0.864 |
Creatinine K, µmol/L | 84.0±258 | 85.0±24.2 | 81.6±20.0 | 89.7±28.3 | 74.6±36.7 | 0.505 |
Uric acid, mmol/L | 0.29±0.09 | 0.29±0.10 | 0.30±0.10 | 0.28±0.10 | 0.28±0.08 | 0.965 |
E-selectin, ng/mL | 32.5±16.8 | 33.5±19.8 | 30.4±14.6 | 34.4±17.3 | 30.6±14.6 | 0.855 |
VCAM-1, ng/mL | 990.0±270.3 | 994.3±330.3 | 899.7±214.7 | 1080.2±282.0 | 998.9±118.3 | 0.196 |
ICAM-1, ng/mL | 152.2±53.7 | 152.6±68.4 | 161.9±58.0 | 144.9±39.5 | 144.0±21.1 | 0.695 |
MMP9, ng/mL | 324.2±156.4 | 348.8±198.5 | 302.9±127.7 | 351.8±146.3 | 252.2±102.6 | 0.325 |
Number of individuals in parentheses. Continuous variables are presented as the mean ± standard deviation and compared using the Kruskal–Wallis test or ANOVA. Categorical variables were compared using the Chi-square test. HDL: high-density lipoprotein; LDL: low-density lipoprotein; AST: alanine aminotransferase; and ALT: aspartate aminotransferase. p-values <0.05 were considered statistically significant.